Loxapine hydrochloride

This classification denotes a serotonin antagonist and dopamine antagonist with the molecular formula C18H18ClN3O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 376MYL4MAL, chemically known as 2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine monohydrochloride but more generally known as loxapine hydrochloride, which bears US NIH Compound Identifier 71400. European Medicines Agency schedules Loxapine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22686. Most nations, for tariff and trade purposes, schedule loxapine hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, LOXAPINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Loxapine hydrochloride bears US NLM identifiers UMLS ID C0304390 and NCI Concept Code C77574. SMILES: CN1CCN(CC1)C2=NC3CCCCC3OC4C2CC(CC4)CL.CL.